XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock Options Activity under Plans

The following table summarizes stock option activity, which includes Performance Awards, under the 2012 Plan, the 2015 Plan, the 2018 Fourth Amended Plan and the 2021 Inducement Plan during the six months ended June 30, 2022:

 

 

 

Stock Options
Outstanding

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Balance at December 31, 2021

 

 

8,640,951

 

 

$

4.74

 

 

 

 

 

 

 

Options granted

 

 

8,828,368

 

 

$

0.84

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

(1,678,488

)

 

$

3.48

 

 

 

 

 

 

 

Options expired

 

 

(692,913

)

 

$

6.23

 

 

 

 

 

 

 

Balance at June 30, 2022

 

 

15,097,918

 

 

$

2.53

 

 

 

8.64

 

 

$

48

 

Vested and expected to vest at June 30, 2022

 

 

15,097,918

 

 

$

2.53

 

 

 

8.60

 

 

$

48

 

Vested and exercisable at June 30, 2022

 

 

3,113,396

 

 

$

5.72

 

 

 

4.74

 

 

$

 

Summary of Assumptions used to Determine Fair Value of Stock Options Granted The following table sets forth the assumptions used to determine the fair value of stock options granted during the six months ended June 30, 2022:

 

Risk-free interest rate

 

2.0% - 3.6%

Expected volatility

 

90.7% - 101.3%

Expected dividend yield

 

%

Expected life (years)

 

5.5 - 6.3 years

Summary of Restricted Stock Units Activity

The following table summarizes RSU activity for the six months ended June 30, 2022:

 

 

 

Number of Shares

 

 

Weighted-
Average Grant
Date Fair Value

 

Balance at December 31, 2021

 

 

3,879,110

 

 

$

3.80

 

Granted

 

 

5,277,244

 

 

$

0.84

 

Vested

 

 

(604,689

)

 

$

4.04

 

Forfeited/cancelled

 

 

(1,048,215

)

 

$

3.49

 

Balance at June 30, 2022

 

 

7,503,450

 

 

$

1.74

 

Schedule of Stock-based Compensation Expense

The following table presents total stock-based compensation expense included in each functional line item in the accompanying condensed consolidated statements of operations (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

 

$

26

 

 

$

1,080

 

 

$

363

 

 

$

1,675

 

Selling, general and administrative

 

 

1,420

 

 

 

2,310

 

 

 

3,136

 

 

 

3,950

 

Discontinued operations

 

 

 

 

 

1,080

 

 

 

 

 

 

1,475

 

Total stock-based compensation expense

 

$

1,446

 

 

$

4,470

 

 

$

3,499

 

 

$

7,100